GSK-3β inhibitor 13 (compound 47) is an orally active and potent GSK-3β inhibitor with blood-brain barrier permeability; it inhibits GSK-3β and GSK-3α with IC50 values of 0.73 nM and 0.35 nM, respectively, and significantly reduces tau phosphorylation (IC50 = 58 nM), which is associated with the formation of neurofibrillary tangles in Alzheimer's disease.